Cumulative doses of anthracyclines. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Heart Myocardium Tumor Cells, Cultured Cell Line, Tumor

Organisms3

Streptomyces Dogs Rats, Sprague-Dawley

Diseases27

Breast Neoplasms Heart Diseases Leukemia P388 Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Cardiomyopathies Neoplasm Metastasis Peripheral Nervous System Diseases Neutropenia Leukemia L1210 Leukemia Leukemia, Radiation-Induced Neoplasms, Second Primary Radiation Injuries Neoplasms, Radiation-Induced Asthma Neurotoxicity Syndromes Recurrence Alopecia Lung Neoplasms Heart Failure Disease Progression Leukemia, Myeloid, Acute Psoriasis Pregnancy Complications, Neoplastic Testicular Neoplasms Acute Disease

Chemicals and Drugs71

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Daunorubicin Doxorubicin Aclarubicin Epirubicin Razoxane Carubicin Idarubicin Antineoplastic Agents Taxoids Nogalamycin Cyclophosphamide Fenoterol Bridged Compounds Paclitaxel Mitoxantrone DNA Topoisomerases, Type II Aconitic Acid Antineoplastic Agents, Phytogenic Fluorouracil Etoposide Vinblastine Vincristine Methotrexate P-Glycoprotein Anthraquinones Liposomes Dexrazoxane Cisplatin Antineoplastic Agents, Alkylating Cardiotoxins Receptor, erbB-2 Albuterol Hydromorphone Deoxycytidine Methacholine Chloride Topoisomerase II Inhibitors Verapamil Cytarabine Bronchodilator Agents Antibodies, Monoclonal Prednisolone Mechlorethamine Intercalating Agents Bronchoconstrictor Agents Glucocorticoids Organoplatinum Compounds Prednisone Leukotriene C4 Terbutaline Antibodies, Monoclonal, Humanized Trifluoperazine Phthalic Acids Mitomycin Epothilones Antigens, Neoplasm Analgesics, Opioid Aerosols Multidrug Resistance-Associated Proteins Procarbazine Calreticulin Iodine Radioisotopes Ifosfamide Glycosides Antimetabolites, Antineoplastic Cardiotonic Agents Bleomycin Lactoperoxidase Asparaginase

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Radiation Dosage Infusions, Intravenous Chemotherapy, Adjuvant Disease-Free Survival Dose-Response Relationship, Radiation Radiometry Retrospective Studies Risk Factors Survival Analysis Double-Blind Method Radiotherapy Dosage Radiotherapy Remission Induction Injections, Intravenous Prospective Studies Follow-Up Studies Nebulizers and Vaporizers Administration, Oral Forced Expiratory Volume Bronchial Provocation Tests Administration, Inhalation PUVA Therapy Clinical Trials as Topic Salvage Therapy Survival Rate Combined Modality Therapy Case-Control Studies Radiography Multivariate Analysis Risk Assessment Prognosis Airway Resistance Drug Screening Assays, Antitumor Echocardiography Drug Evaluation Neoplasm Staging Lethal Dose 50 Heart Rate Blood Pressure Vital Capacity Incidence

Phenomena and Processes20

Dose-Response Relationship, Drug Time Factors Radiation Dosage Drug Resistance, Multiple Dose-Response Relationship, Radiation Drug Resistance, Neoplasm Drug Interactions Drug Resistance Forced Expiratory Volume Airway Resistance Drug Tolerance Cell Survival Ventricular Function, Left Lethal Dose 50 Heart Rate Biotransformation Structure-Activity Relationship Blood Pressure Apoptosis Vital Capacity

Technology, Industry, Agriculture1

Information Science2

Survival Rate Incidence

Named Groups1

Health Care18

Treatment Outcome Radiation Dosage Disease-Free Survival Dose-Response Relationship, Radiation Retrospective Studies Risk Factors Survival Analysis Double-Blind Method Prospective Studies Follow-Up Studies Radiation Injuries Clinical Trials as Topic Survival Rate Case-Control Studies Multivariate Analysis Occupational Exposure Risk Assessment Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Named Groups Health Care

Anthracyclines Naphthacenes Antibiotics, Antineoplastic Daunorubicin Doxorubicin Aclarubicin Epirubicin Razoxane Carubicin Antineoplastic Combined Chemotherapy Protocols Idarubicin Dose-Response Relationship, Drug Antineoplastic Agents Breast Neoplasms Drug Administration Schedule Heart Diseases Taxoids Treatment Outcome Nogalamycin Cyclophosphamide Fenoterol Bridged Compounds Leukemia P388 Time Factors Neoplasms Radiation Dosage Paclitaxel Mitoxantrone DNA Topoisomerases, Type II Infusions, Intravenous Chemotherapy, Adjuvant Aconitic Acid Antineoplastic Agents, Phytogenic Fluorouracil Etoposide Vinblastine Vincristine Disease-Free Survival Drug Resistance, Multiple Methotrexate Heart Precursor Cell Lymphoblastic Leukemia-Lymphoma P-Glycoprotein Cardiomyopathies Dose-Response Relationship, Radiation Radiometry Drug Resistance, Neoplasm Drug Interactions Anthraquinones Retrospective Studies Liposomes Dexrazoxane Neoplasm Metastasis Risk Factors Cisplatin Survival Analysis Antineoplastic Agents, Alkylating Cardiotoxins Peripheral Nervous System Diseases Survivors Receptor, erbB-2 Double-Blind Method Radiotherapy Dosage Radiotherapy Albuterol Drug Resistance Remission Induction Neutropenia Hydromorphone Deoxycytidine Leukemia L1210 Leukemia Methacholine Chloride Injections, Intravenous Prospective Studies Follow-Up Studies Topoisomerase II Inhibitors Nebulizers and Vaporizers Leukemia, Radiation-Induced Administration, Oral Neoplasms, Second Primary Verapamil Forced Expiratory Volume Radiation Injuries Bronchial Provocation Tests Administration, Inhalation PUVA Therapy Clinical Trials as Topic Streptomyces Myocardium Neoplasms, Radiation-Induced Cytarabine Salvage Therapy Survival Rate Combined Modality Therapy Asthma Bronchodilator Agents Antibodies, Monoclonal Case-Control Studies Prednisolone

No FAQ available that match "cumulative doses of anthracyclines"